Attitudes towards predictive testing in Huntington's disease: a recent survey in Belgium.

Demand for DNA probe testing in three genetic centres in Britain (August 1986 to July 1987). J Med Genet (1989) 1.95

Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. Am J Hum Genet (1994) 1.34

Psychological impact of genetic testing for Huntington's disease: an update of the literature. J Neurol Neurosurg Psychiatry (2000) 1.24

Paradox of a better test for Huntington's disease. J Neurol Neurosurg Psychiatry (2000) 1.23

Huntington's disease and the ethics of genetic prediction. J Med Ethics (1992) 1.15

Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet (1996) 1.08

Attitudes of general practitioners to presymptomatic testing for Huntington's disease. J Med Genet (1990) 1.01

Attitudes of neurologists, psychiatrists, and psychotherapists towards predictive testing for Huntington's disease in Germany. J Med Genet (1993) 0.86

Exclusion testing in pregnancy for Huntington's disease. J Med Genet (1990) 0.82

Psychological effect of genetic testing for Huntington's disease: an update of the literature. West J Med (2001) 0.81

Couples at risk for spinocerebellar ataxia type 2: the Cuban prenatal diagnosis experience. J Community Genet (2013) 0.80

Knowledge and attitudes towards genetic testing in those affected with Parkinson's disease. J Community Genet (2013) 0.78

Intelligence indices in people with a high/low risk for developing Huntington's disease. J Med Genet (1997) 0.75

22 Years of predictive testing for Huntington's disease: the experience of the UK Huntington's Prediction Consortium. Eur J Hum Genet (2016) 0.75

A polymorphic DNA marker genetically linked to Huntington's disease. Nature (1984) 16.71

Attitudes of families to some aspects of Huntington's chorea. Psychol Med (1979) 2.40

Attitudes of patients and their relatives to Huntington's disease. J Med Genet (1975) 1.96

Attitudes of subjects at risk and their relatives towards genetic counselling in Huntington's chorea. J Med Genet (1983) 1.67

A DNA polymorphism for Huntington's disease marks the future. Arch Neurol (1985) 1.43

Objective knowledge about Huntington's disease and attitudes towards predictive tests of persons at risk. J Med Genet (1981) 1.41

Potential impact of a predictive test on the gene frequency of Huntington disease. Am J Med Genet (1984) 1.10

The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene (2001) 2.97

Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet (1996) 2.88

Impact of genetic counseling: a review of published follow-up studies. Clin Genet (1979) 2.88

Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest (1998) 2.68

Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol (1992) 2.61

Distinct haematological disorder with deletion of long arm of no. 5 chromosome. Nature (1974) 2.56

Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56

Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol (1996) 2.42

Primary amines inhibit recycling of alpha 2M receptors in fibroblasts. Cell (1980) 2.40

A child, homozygous for a stop codon in exon 11, shows milder cystic fibrosis symptoms than her heterozygous nephew. J Med Genet (1990) 2.30

Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet (1997) 2.30

Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene (1999) 2.10

Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood (1996) 2.02

Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J Cell Biol (1990) 1.88

Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making. J Med Genet (1996) 1.84

Huntington disease: no evidence for locus heterogeneity. Genomics (1989) 1.70

Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A. Am J Hum Genet (1998) 1.66

Partial primary structure of the 48- and 90-kilodalton core proteins of cell surface-associated heparan sulfate proteoglycans of lung fibroblasts. Prediction of an integral membrane domain and evidence for multiple distinct core proteins at the cell surface of human lung fibroblasts. J Biol Chem (1989) 1.64

Correlations between triplet repeat expansion and clinical features in Huntington's disease. Arch Neurol (1995) 1.59

Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59

Linkage analysis in three families with nonspecific X-linked mental retardation. Am J Med Genet (1996) 1.59

Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol (1992) 1.51

Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants. Genet Couns (1995) 1.51

Multiple distinct membrane heparan sulfate proteoglycans in human lung fibroblasts. J Biol Chem (1989) 1.48

Adolescents' attitude towards carrier testing for cystic fibrosis and its relative stability over time. Eur J Hum Genet (1996) 1.48

Philadelphia chromosome-positive chronic myelogenous leukemia in treated Hodgkin's disease. Cancer Genet Cytogenet (1990) 1.45

Demonstration of an alpha2-macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines. J Biol Chem (1979) 1.45

t(1;19) without detectable E2A rearrangements in two t(14;18)-positive lymphoma/leukemia cases. Genes Chromosomes Cancer (1994) 1.41

Mental retardation with pterygia, shortness and distinct facial appearance. A new MCA/MR syndrome. Clin Genet (1985) 1.40

The female and the fragile X syndrome: data on clinical and psychological findings in 7 fra(X) carriers. Clin Genet (1990) 1.40

Non-syndromic deafness associated with a mutation and a polymorphism in the mitochondrial 12S ribosomal RNA gene in a large Zairean pedigree. Eur J Hum Genet (1996) 1.40

Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers. Blood (1992) 1.39

Fertility and X-chromosome rearrangements: isodicentric X-chromosome formation in the mother and Xp deletion in her daughter. Clin Genet (1988) 1.39

On the familial occurrence of congenital bilateral absence of vas deferens. Clin Genet (1989) 1.38

Variant t(2;18) translocation in a Burkitt conversion of follicular lymphoma. Br J Haematol (1990) 1.38

TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosomes Cancer (1994) 1.37

Uptake and degradation of alpha2-macroglobulin-protease complexes in human cells in culture. Exp Cell Res (1978) 1.35

Malformative syndrome associated with a ring 10 chromosome and a translocated 10q/19 chromosome. Hum Genet (1978) 1.34

Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts. J Biol Chem (1992) 1.33

The Brachmann-de Lange syndrome in two siblings of normal parents. Clin Genet (1987) 1.32

Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. J Biol Chem (1992) 1.32

Detection of bacterial and mycoplasma contamination in cell cultures by polymerase chain reaction. FEMS Microbiol Lett (1992) 1.31

Recommendations for the predictive genetic test in Huntington's disease. Clin Genet (2012) 1.27

Diaphragmatic defects, craniofacial dysmorphism, cleft palate and distal limb deformities. - a new lethal syndrome. J Genet Hum (1980) 1.25

Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. Am J Hum Genet (1997) 1.25

Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features. Haematologica (1997) 1.23

Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens (1993) 1.22

Coping and the ineffectiveness of coping influence the outcome of in vitro fertilization through stress responses. Psychoneuroendocrinology (1992) 1.22

Established cell lines used in cystic fibrosis research. J Cyst Fibros (2004) 1.21

Cystic fibrosis: community knowledge and attitudes towards carrier screening and prenatal diagnosis. Clin Genet (1992) 1.21

Distribution of the beta 1 subgroup of the integrins in human cells and tissues. J Histochem Cytochem (1989) 1.20

Relationship of transformation, cell density, and growth control to the cellular distribution of newly synthesized glycosaminoglycan. J Cell Biol (1976) 1.20

Functional modifications of alpha 2-macroglobulin by primary amines. I. Characterization of alpha 2 M after derivatization by methylamine and by factor XIII. J Biol Chem (1981) 1.20

Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia (1997) 1.19

MASA syndrome: new clinical features and linkage analysis using DNA probes. J Med Genet (1990) 1.19

Prenatal diagnosis in CDG1 families: beware of heterogeneity. Eur J Hum Genet (1998) 1.19

Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group. Am J Pathol (1999) 1.19

Forensic medicine and the polymerase chain reaction technique. J Med Genet (1993) 1.18

Ring chromosome 15 syndrome. Hum Genet (1979) 1.18

Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development (1993) 1.16

X linked complicated spastic paraplegia, MASA syndrome, and X linked hydrocephalus owing to congenital stenosis of the aqueduct of Sylvius: variable expression of the same mutation at Xq28. J Med Genet (1991) 1.16

Interstitial deletion of the long arm of chromosome 15. Ann Genet (1982) 1.16

Quadriceps and grip strength are related to vitamin D receptor genotype in elderly nonobese women. J Bone Miner Res (1997) 1.16

Analysis of 35 cases of localized and diffuse tenosynovial giant cell tumor: a report from the Chromosomes and Morphology (CHAMP) study group. Mod Pathol (1999) 1.15

Heparan sulfate expression in polarized epithelial cells: the apical sorting of glypican (GPI-anchored proteoglycan) is inversely related to its heparan sulfate content. J Cell Biol (1996) 1.15

The Coffin-Siris syndrome: report of a family and further delineation. Clin Genet (1984) 1.15

Report of the committee on structural chromosome changes in neoplasia. Cytogenet Cell Genet (1987) 1.15

Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells. Hum Mol Genet (1997) 1.15

The language of uncertainty in genetic risk communication: framing and verbal versus numerical information. Patient Educ Couns (2001) 1.14

Transmission of fragile (X)(q27) from normal male(s). Hum Genet (1982) 1.13

Heparan sulfate proteoglycans of human lung fibroblasts. Structural heterogeneity of the core proteins of the hydrophobic cell-associated forms. J Biol Chem (1987) 1.13

The preservation and regeneration of cilia on human nasal epithelial cells cultured in vitro. Arch Otorhinolaryngol (1989) 1.13

D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology (1996) 1.12

Germinal mosaicism in achondroplasia: a family with 3 affected siblings of normal parents. Clin Genet (1983) 1.11

Genetic testing and quality control in diagnostic laboratories. Nat Genet (2000) 1.10

Fertility in patients with X chromosome deletions. Clin Genet (1982) 1.10

Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year. Acta Neurol Scand (2002) 1.07

P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myeloma. Leukemia (1990) 1.07

Detection of 98.5% of the mutations in 200 Belgian cystic fibrosis alleles by reverse dot-blot and sequencing of the complete coding region and exon/intron junctions of the CFTR gene. Genomics (1993) 1.07

Calcification of cartilages, brachytelephalangy and peripheral pulmonary stenosis. Confirmation of the Keutel syndrome. Eur J Pediatr (1984) 1.07

Growth properties and in vitro life span of Alzheimer disease and Down syndrome fibroblasts. A blind study. Mech Ageing Dev (1990) 1.06

Order of genes on human chromosome 5q with respect to 5q interstitial deletions. Am J Hum Genet (1990) 1.06

Recommendations for quality improvement in genetic testing for cystic fibrosis. European Concerted Action on Cystic Fibrosis. Eur J Hum Genet (2000) 1.06

Autosomal whole arm translocations in man. A patient with t(5p7p;5q7q) type rearrangement and review of the literature. Clin Genet (1986) 1.06

Mutations in L1-CAM in two families with X linked complicated spastic paraplegia, MASA syndrome, and HSAS. J Med Genet (1995) 1.05

Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator. Hum Mol Genet (1998) 1.05

Identification of a 64 kDa heparan sulphate proteoglycan core protein from human lung fibroblast plasma membranes with a monoclonal antibody. Biochem J (1987) 1.05

The motivation of at-risk individuals and their partners in deciding for or against predictive testing for Huntington's disease. Clin Genet (1989) 1.05

Partial monosomy of the long arm of chromosome 16 in a malformed newborn: karyotype 46,XX,del(16))q21). Hum Genet (1977) 1.04

Peripheral primitive neuroectodermal tumour of the cervix. Virchows Arch (2000) 1.04

Regional localization of two genes for nonspecific X-linked mental retardation to Xp22.3-p22.2 (MRX49) and Xp11.3-p11.21 (MRX50). Am J Med Genet (1997) 1.04

Cognitive representations of breast cancer, emotional distress and preventive health behaviour: a theoretical perspective. Psychooncology (2001) 1.03

The elfin face syndrome and the short arm of chromosome 15. Ann Genet (1982) 1.03

Matrix-associated heparan sulfate proteoglycan: core protein-specific monoclonal antibodies decorate the pericellular matrix of connective tissue cells and the stromal side of basement membranes. J Cell Biol (1989) 1.03